Results 31 to 40 of about 155,441 (160)

Lupus Pneumonitis Therapy Masks Coronavirus (COVID-19)

open access: yes, 2021
Introduction. Coronavirus pneumonitis can mimic, or present as, lupus pneumonitis. Lupus may cause inflammation of the myocardium. Lupus pneumonitis high-dose steroid therapy may mask coronavirus (COVID-19). Case Study.
A. M. Soloway   +3 more
core   +1 more source

Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis [PDF]

open access: yes, 2020
mmune checkpoint inhibitors (ICI) have become the standard of care treatment for several tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with these agents.
Cornelissen, R. (Robin)   +14 more
core   +2 more sources

Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy

open access: yesBMC Pulmonary Medicine
Background The combination of immune checkpoint inhibitors (ICIs) and thoracic radiotherapy (TRT) has played a significant role in the improvement of tumor therapy, but the increased incidence of pneumonitis has greatly limited its application.
Yang Tang   +9 more
doaj   +1 more source

The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis

open access: yesMedicina, 2020
Background and objectives: Everolimus (EVE) is a mammalian target of the rapamycin (mTOR) inhibitor that is widely used in cancer patients. Pulmonary toxicity, usually manifesting as interstitial pneumonitis, is a serious adverse effect of this drug ...
Mehmet Fuat Eren   +10 more
doaj   +1 more source

Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer

open access: yesFrontiers in Immunology
PurposeThis study evaluates the impact of thoracic radiotherapy (TRT) combined with immune checkpoint inhibitors (ICIs) treatment-related pneumonitis on tumor progression and prognosis in patients with non-small cell lung cancer (NSCLC).MethodsData were ...
Ziwei Wang   +7 more
doaj   +1 more source

Crohn's disease and related inflammatory diseases: from many single hypotheses to one "superhypothesis"

open access: yesVeterinární Medicína, 2014
The aetiology of Crohn's disease and paratuberculosis are the subjects of intensive study and also frequently, of dispute. However, a number of other nosological entities have a similar history, namely type 1 diabetes, multiple sclerosis, sarcoidosis ...
K. Hruska, I. Pavlik
doaj   +1 more source

Bacterial infection in dogs with aspiration pneumonia at 2 tertiary referral practices

open access: yesJournal of Veterinary Internal Medicine, 2021
Background In dogs, antimicrobial drugs are widely prescribed for aspiration pneumonia (AP) despite poor documentation of bacterial infection in AP (b‐AP) using bronchoalveolar lavage fluid (BALF) analysis.
Jennifer Howard   +5 more
doaj   +1 more source

Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC

open access: yesnpj Precision Oncology
Unresectable stage III NSCLC is now treated with chemoradiation (CRT) followed by immune checkpoint inhibitors (ICI). Pneumonitis, a common CRT complication, has heightened risk with ICI, potentially causing severe outcomes.
Lukas Delasos   +11 more
doaj   +1 more source

Docetaxel-induced lung injury: An under-recognized complication of a commonly used chemotherapeutic agent

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Background: Docetaxel-induced pneumonitis is a rare, but potentially serious complication of a commonly used chemotherapeutic agent. Methods: We performed an audit of patients with suspected docetaxel pneumonitis from the tertiary cancer center. Results:
Avaronnan Manuprasad   +6 more
doaj   +1 more source

Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage III non-small-cell lung cancer: a systematic review, meta-analysis, and meta-regression of real-world studies

open access: yesFrontiers in Pharmacology, 2023
Background: The current review aimed to pool real-world evidence on the efficacy and toxicity of consolidation durvalumab for stage III unresectable non-small cell lung cancer (NSCLC) after curative chemoradiotherapy.Methods: PubMed, CENTRAL ...
Yatong Zhang   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy